China Pharma Holdings Inc
CPHI0.694USD
+0.064+10.14%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
3.48MMarket Cap
LossP/E TTM
More Details of China Pharma Holdings Inc Company
China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
China Pharma Holdings Inc Info
Ticker SymbolCPHI
Company nameChina Pharma Holdings Inc
IPO dateFeb 15, 2000
CEOLi (Zhilin)
Number of employees224
Security typeOrdinary Share
Fiscal year-endFeb 15
Address2nd Floor, No. 17, Jinpan Road
CityHAIKOU
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryChina
Postal code570216
Phone8689866811730
Websitehttp://www.chinapharmaholdings.com
Ticker SymbolCPHI
IPO dateFeb 15, 2000
CEOLi (Zhilin)
Company Executives of China Pharma Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Zhilin Li
Ms. Zhilin Li
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
302.76K
+1.00%
Ms. Heung Mei Tsui
Ms. Heung Mei Tsui
Director
Director
18.63K
+1.00%
Mr. Gene Michael Bennett
Mr. Gene Michael Bennett
Independent Director
Independent Director
--
--
Yingwen Zhang
Yingwen Zhang
Independent Director
Independent Director
--
--
Mr. Baowen Dong
Mr. Baowen Dong
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Zhilin Li
Ms. Zhilin Li
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
302.76K
+1.00%
Ms. Heung Mei Tsui
Ms. Heung Mei Tsui
Director
Director
18.63K
+1.00%
Mr. Gene Michael Bennett
Mr. Gene Michael Bennett
Independent Director
Independent Director
--
--
Yingwen Zhang
Yingwen Zhang
Independent Director
Independent Director
--
--
Mr. Baowen Dong
Mr. Baowen Dong
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
By BusinessUSD
Name
Revenue
Proportion
Domestic Pharmaceuticals
756.22K
0.00%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Domestic Pharmaceuticals
756.22K
0.00%
Shareholding Stats
Updated: Fri, Jan 2
Updated: Fri, Jan 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Yang (Yan)
8.96%
Zhan (Wenlong)
8.16%
Jianying (Cai)
7.96%
Lai (Kui)
7.96%
Lihua (Li)
7.96%
Other
58.98%
Shareholders
Shareholders
Proportion
Yang (Yan)
8.96%
Zhan (Wenlong)
8.16%
Jianying (Cai)
7.96%
Lai (Kui)
7.96%
Lihua (Li)
7.96%
Other
58.98%
Shareholder Types
Shareholders
Proportion
Individual Investor
53.39%
Hedge Fund
0.82%
Investment Advisor
0.01%
Other
45.78%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
15
76.44K
2.51%
--
2025Q3
15
76.44K
3.87%
-42.24K
2025Q2
15
118.68K
1.40%
+84.90K
2025Q1
14
33.79K
0.88%
+5.19K
2024Q4
14
17.38K
1.34%
+13.31K
2024Q3
13
4.07K
1.47%
-1.93K
2024Q2
13
6.00K
1.31%
-5.59K
2024Q1
11
11.59K
0.89%
-1.57K
2023Q4
12
12.24K
0.98%
+6.13K
2023Q3
12
6.11K
1.50%
+3.00K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Yang (Yan)
450.00K
8.96%
+450.00K
--
Nov 03, 2025
Zhan (Wenlong)
410.00K
8.16%
+410.00K
--
Nov 03, 2025
Jianying (Cai)
400.00K
7.96%
+300.00K
+300.00%
Nov 03, 2025
Lai (Kui)
400.00K
7.96%
+300.00K
+300.00%
Nov 03, 2025
Lihua (Li)
400.00K
7.96%
+300.00K
+300.00%
Nov 03, 2025
Li (Zhilin)
302.76K
6.03%
+1.00
+0.00%
Nov 03, 2025
Liu (Tao Chengdu)
300.00K
5.97%
--
--
Nov 03, 2025
Citadel Advisors LLC
30.43K
0.61%
+7.36K
+31.89%
Sep 30, 2025
Tsui (Heung Mei)
18.63K
0.37%
+1.00
+0.01%
Nov 03, 2025
Renaissance Technologies LLC
10.62K
0.21%
+10.62K
--
Sep 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Apr 04, 2025
Merger
10→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Feb 24, 2023
Merger
10→1
Date
Ex-dividend Date
Type
Ratio
Apr 04, 2025
Merger
10→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Feb 24, 2023
Merger
10→1
Feb 24, 2023
Merger
10→1
Feb 24, 2023
Merger
10→1
Feb 24, 2023
Merger
10→1
